Indiana University

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Indiana University sits in the top decile of US sponsors by registered trial count (#38 of 15,742 sponsors by registered trial count).

890 total trials 156 currently recruiting 561 completed top decile by trial count

Indiana University: 890 sponsored US clinical trials, 156 recruiting.

Indiana University sponsors 890 registered US clinical trials on ClinicalTrials.gov, 156 of them currently recruiting, and 561 completed. 104 of these trials are in Phase 3-4 (later-stage) and 126 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Alzheimer Disease, with 11 trials.

Top-decile sponsor footprint

Indiana University ranks in the top decile of sponsors by registered trial count (#38 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 43/100

561 of 688 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

890 total, page 10 of 18

COMPLETED NA

The Aging Brain ANSWERS Program

NCT03397667

COMPLETED

Dissecting the Genetics of Fetal Alcohol Spectrum Disorders

NCT04072809

COMPLETED NA

Evaluation of an Exercise Intervention for Vincristine Induced Peripheral Neuropathy in Pediatric Cancer Patients

NCT03430674

COMPLETED

Opioid Use After Traumatic Injury in Adolescents

NCT03628846

COMPLETED Phase 2

Evaluation of Oral Plaque Removal Utilizing an Adjunct Enzyme Pre-rinse

NCT04512482

COMPLETED NA

Improving Patient Communication About SUDEP

NCT03502759

COMPLETED Early Phase 1

Bupropion Stereoselective Disposition and CYP2D6-mediated Drug Interactions in Healthy Volunteers

NCT03420469

COMPLETED

Efficacy of Psychological Therapies in Patients With Functional Bowel Disorders

NCT04060121

COMPLETED NA

Comparing 3 Different Types of Pain Blocks After Laparoscopic Nephrectomy

NCT03581539

COMPLETED NA

Canine Assisted Therapy to Reduce Emergency Care Provider Stress

NCT03628820

COMPLETED NA

Training to Reconnect With Emotional Awareness Therapy

NCT03414463

COMPLETED

Determinants of Early Cystic Fibrosis Lung Disease

NCT03579173

COMPLETED NA

Cognitive Behavioral Therapy to Treat Insomnia in Persons With HIV Infection

NCT03390114

COMPLETED Phase 4

Intravenous Iron for Iron-deficiency Anemia in Pregnancy: a Randomized Controlled Trial

NCT03438227

COMPLETED NA

Endocuff Vision Colonoscopy vs. AmplifEYE Colonoscopy

NCT03560128

TERMINATED NA

Human Alcohol Seeking Despite Aversion

NCT03648840

COMPLETED NA

Pre-operative Stereotactic Radiosurgery Followed by Resection for Patients With Brain Metastases

NCT03398694

COMPLETED

Reducing Sedentary Time in Fibromyalgia Patients

NCT03247348

COMPLETED NA

Mobile Goal-setting Intervention to Improve Vegetable Intake Among Young College Students

NCT04242693

COMPLETED NA

Project POINT: Effectiveness and Scalability of an Overdose Survivor Intervention

NCT03336268

COMPLETED NA

Quad Resection (Hot Snare vs Cold Snare vs Hot EMR vs Cold EMR)

NCT03462706

COMPLETED NA

Infant Behavioral Sleep Intervention: Comparative Efficacy

NCT03447665

COMPLETED NA

Mindfulness-Based Stress Reduction for Adults With Low-Risk Chest Pain Associated With Anxiety

NCT03365375

COMPLETED NA

Study of Mind-Body Skills Groups for Adolescents With Depression in Primary Care

NCT03363750

COMPLETED NA

EndoRings Colonoscopy vs Standard Colonoscopy

NCT03418662

COMPLETED NA

Effects of an 8-day Advanced Meditation, Samyama on Physical, Psychological and Spiritual Wellbeing ,and Associated Neural Mechanisms

NCT04366544

COMPLETED

Implementation and Evaluation of SBIRT

NCT03560076

COMPLETED NA

The Effects of Postoperative Physician Phone Calls for Hand and Wrist Fractures

NCT03557073

TERMINATED NA

Radial Forearm Versus the Ulnar Forearm Free Flap

NCT03579277

COMPLETED

Canine-assisted ANxiety Reduction IN Emergency

NCT03471429

COMPLETED NA

Sipuleucel-T and Low-protein Diet in Patients With Metastatic Castrate-resistant Prostate Cancer

NCT03329742

COMPLETED NA

Detecting and Evaluating Childhood and Anxiety and Depression Effectively in Subspecialties

NCT02773706

COMPLETED NA

Automated Youth-To-Adult Transition Planning Using Health Information ...

NCT03371875

TERMINATED Phase 2

Nitroglycerin vs. Furosemide Using Lung Ultrasound Pilot Trial

NCT03259165

COMPLETED NA

Standard Colonoscopy Versus Colonoscopy With Endocuff Vision

NCT03361917

COMPLETED NA

Short Stay Unit vs Hospitalization in Acute Heart Failure

NCT03302910

COMPLETED NA

Decisions About Cancer Screening in Alzheimer's Disease

NCT03282097

COMPLETED

Identification of β Cell Dysfunction in Relatives of Individuals With Type 1 Diabetes Mellitus

NCT04362917

COMPLETED NA

Innovative Approaches for Minor Consent: Consent 2.0

NCT03242954

TERMINATED NA

Optimizing the Social Engagement System in Prader-Willi Syndrome: Insights From the Polyvagal Theory

NCT03101826

TERMINATED NA

Pediatric Robotic Versus Open Pyeloplasty

NCT04884945

COMPLETED NA

Developing SUPPORT, a Community-Driven, Recovery-Oriented System of Care

NCT03132753

TERMINATED Phase 1

Five Fraction SABR Dose Escalation for Early Stage Squamous Cell Carcinoma of the Lung

NCT03321747

COMPLETED Phase 4

A Comparison of Eleview Versus Hetastarch as Injectate for EMR

NCT03350217

COMPLETED NA

Trauma Medical Home for Older Injured Patients

NCT03108820

TERMINATED Phase 4

Evaluation of Glycerin Suppositories to Improve Bowel Function in Gastroschisis

NCT03355326

COMPLETED NA

Improving the Recovery and Outcome Every Day After the ICU

NCT03095417

TERMINATED NA

Pilot Phase 2 Study Whole Brain Radiation Therapy With Simultaneous Integrated Boost for Patients With Brain Metastases

NCT03189381

COMPLETED NA

Intraductal Secretin Stimulation Test: What Is the Proper Collection Time?

NCT03263481

COMPLETED Phase 4

Effect of an H1 Receptor Antagonist on Exercise Performance in Hypoxia

NCT03192488

← Previous Page 10 of 18 Next →

Phase Distribution

PhaseTrial count
Phase 1 56
Phase 2 70
Phase 3 28
Phase 4 76

What is open in the Indiana University pipeline

156 recruiting of 890 indexed (18% open); 561 completed (63%).

Phase mix: 104 late (III/IV) vs 126 early (I/II) (balanced across stages).

Top condition: Alzheimer Disease (11 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Indiana University: open-pipeline peers nationwide

Peers matched on 890 registered trials and 18% open enrollment, not the therapeutic-area sidebar.

Indiana University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,5002,000 5%10%15%20% Total trials Recruiting share Indiana UniversityUniversity of California, Los AngelesHoffmann-La RocheBrigham and Women's HospitalUniversity of Texas Southwestern Medical CenterEdwards LifesciencesUniversity of South FloridaVA Office of Research and DevelopmentConvaTec
Indiana University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Indiana University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 890 trials (± recruiting share)

Sponsors near 18% open enrollment (± trial volume)

What to do with this Indiana University page

890 registered trials is a research-attention snapshot, not an endorsement of Indiana University or any single study.

  • 156 of Indiana University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Alzheimer Disease is the condition Indiana University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Alzheimer Disease trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Indiana University pipeline card: 890 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.